相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pathogenic Aβ generation in familial Alzheimer's disease: novel mechanistic insights and therapeutic implications
Johannes Trambauer et al.
CURRENT OPINION IN NEUROBIOLOGY (2020)
Nanobody interaction unveils structure, dynamics and proteotoxicity of the Finnish-type amyloidogenic gelsolin variant
Toni Giorgino et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Trafficking and proteolytic processing of amyloid precursor protein and secretases in Alzheimer's disease development: An up-to-date review
Melike Yuksel et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Lowering of Amyloid-Beta by β-Secretase Inhibitors - Some Informative Failures
David S. Knopman
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Tau local structure shields an amyloid-forming motif and controls aggregation propensity
Dailu Chen et al.
NATURE COMMUNICATIONS (2019)
Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer's brain tissue
Marius Kollmer et al.
NATURE COMMUNICATIONS (2019)
Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
Ronald C. Petersen et al.
NEUROLOGY (2018)
The Neuronal Tau Protein Blocks in Vitro Fibrillation of the Amyloid-beta (A beta) Peptide at the Oligomeric Stage
Cecilia Wallin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Tau-targeting therapies for Alzheimer disease
Erin E. Congdon et al.
NATURE REVIEWS NEUROLOGY (2018)
Phosphorylation of different tau sites during progression of Alzheimer's disease
Joerg Neddens et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Humanin Specifically Interacts with Amyloid-β Oligomers and Counteracts Their in vivo Toxicity
Margherita Romeo et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding
I. Moreno-Gonzalez et al.
MOLECULAR PSYCHIATRY (2017)
Cryo-EM structures of tau filaments from Alzheimer's disease
Anthony W. P. Fitzpatrick et al.
NATURE (2017)
Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
K. Hoglund et al.
TRANSLATIONAL PSYCHIATRY (2017)
HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders
Yasmin Zeinolabediny et al.
SCIENTIFIC REPORTS (2017)
Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo
Bruno Vasconcelos et al.
ACTA NEUROPATHOLOGICA (2016)
Is phosphorylated tau unique to chronic traumatic encephalopathy? Phosphorylated tau in epileptic brain and chronic traumatic encephalopathy
Vikram Puvenna et al.
BRAIN RESEARCH (2016)
The Anti-Prion Antibody 15B3 Detects Toxic Amyloid-β Oligomers
Matteo Stravalaci et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Cross-interactions between the Alzheimer Disease Amyloid-β Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis
Jinghui Luo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Clusterin Binds to A1-42 Oligomers with High Affinity and Interferes with Peptide Aggregation by Inhibiting Primary and Secondary Nucleation
Marten Beeg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Molecular mechanisms of protein aggregation from global fitting of kinetic models
Georg Meisl et al.
NATURE PROTOCOLS (2016)
A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers
Samuel I. A. Cohen et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Tau Hyperphosphorylation and Oxidative Stress, a Critical Vicious Circle in Neurodegenerative Tauopathies?
Seyedeh Maryam Alavi Naini et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
A molecular chaperone breaks the catalytic cycle that generates toxic Aβ oligomers
Samuel I. A. Cohen et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2015)
Synaptic Contacts Enhance Cell-to-Cell Tau Pathology Propagation
Sara Calafate et al.
CELL REPORTS (2015)
A Caenorhabditis elegans-based assay recognizes immunoglobulin light chains causing heart amyloidosis
Luisa Diomede et al.
BLOOD (2014)
Monoclonal Antibodies against Aβ42 Fibrils Distinguish Multiple Aggregation State Polymorphisms in Vitro and in Alzheimer Disease Brain
Asa Hatami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Interactions between Amyloid-β and Tau Fragments Promote Aberrant Aggregates: Implications for Amyloid Toxicity
Thanh D. Do et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2014)
Different mutations at V363 MAPT codon are associated with atypical clinical phenotypes and show unusual structural and functional features
Giacomina Rossi et al.
NEUROBIOLOGY OF AGING (2014)
Alzheimer's therapeutics: Continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond?
Kevin Mullane et al.
BIOCHEMICAL PHARMACOLOGY (2013)
Novel approaches for studying amyloidogenic peptides/proteins
Marten Beeg et al.
CURRENT OPINION IN PHARMACOLOGY (2013)
Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism
Samuel I. A. Cohen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Specific Recognition of Biologically Active Amyloid-β Oligomers by a New Surface Plasmon Resonance-based Immunoassay and an in Vivo Assay in Caenorhabditis elegans
Matteo Stravalaci et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
From Macroscopic Measurements to Microscopic Mechanisms of Protein Aggregation
Samuel I. A. Cohen et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers
Benedetta Mannini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A modified protocol to prepare seed-free starting solutions of amyloid-β (Aβ)1-40 and Aβ1-42 from the corresponding depsipeptides
Marten Beeg et al.
ANALYTICAL BIOCHEMISTRY (2011)
Synergistic Interactions between Repeats in Tau Protein and Aβ Amyloids May Be Responsible for Accelerated Aggregation via Polymorphic States
Yifat Miller et al.
BIOCHEMISTRY (2011)
CSF biomarkers for Alzheimer's disease: current utility and potential future use
David M. Holtzman
NEUROBIOLOGY OF AGING (2011)
Quantitative Characterization of Heparin Binding to Tau Protein IMPLICATION FOR INDUCER-MEDIATED TAU FILAMENT FORMATION
Hai-Li Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
LOSS OF TAU ELICITS AXONAL DEGENERATION IN A MOUSE MODEL OF ALZHEIMER'S DISEASE
H. N. Dawson et al.
NEUROSCIENCE (2010)
Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein
Claudia Balducci et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
An Analytical Solution to the Kinetics of Breakable Filament Assembly
Tuomas P. J. Knowles et al.
SCIENCE (2009)
Aβ and tau form soluble complexes that may promote self aggregation of both into the insoluble forms observed in Alzheimer's disease
JP Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Tau protein and neurodegeneration
M Goedert
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2004)
分享论文
